Ralph Schwall
Impact in
- Hepatology top 0.5%
- Liver physiology and pathology
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
Papers in
-
- TGF-β signaling in diseases 28
- Metabolism, Diabetes, and Cancer 6
- Hepatology 24
- Liver physiology and pathology 24
- Co-authors
- Anthony J. Mason (17 shared papers)Hartmut Koeppen (7 shared papers)Sharon Fong (6 shared papers)David A. Lawrence (4 shared papers)Avi Ashkenazi (4 shared papers)Andrea Hebert (1 shared paper)Ling Chang (1 shared paper)Zahra Shahrokh (1 shared paper)
- Journals
- Endocrinology (10 papers)Cancer Research (6 papers)Journal of Biological Chemistry (6 papers)Hepatology (4 papers)Molecular Endocrinology (4 papers)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Ralph Schwall
85 papers receiving 9.9k citations
Ralph Schwall's Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 1.3k
- Oncology 2.4k
- Molecular Biology 5.7k
- Cancer Research 1.0k
- Reproductive Medicine 548
Countries citing papers authored by Ralph Schwall
This map shows the geographic impact of Ralph Schwall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Schwall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Schwall more than expected).
Fields of papers citing papers by Ralph Schwall
This network shows the impact of papers produced by Ralph Schwall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Schwall. The network helps show where Ralph Schwall may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralph Schwall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and antitumor activity of recombinant soluble Apo2 ligand Hit paper breakdown → | 1999 | 1895 |
| 2 | Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate Hit paper breakdown → | 2008 | 1273 |
| 3 | Vascular endothelial growth factor is essential for corpus luteum angiogenesis Hit paper breakdown → | 1998 | 514 |
| 4 | 2002 | 430 | |
| 5 | 2006 | 377 | |
| 6 | 1998 | 377 | |
| 7 | 2001 | 323 | |
| 8 | 2006 | 243 | |
| 9 | 1991 | 218 | |
| 10 | 2007 | 206 | |
| 11 | 1985 | 182 | |
| 12 | 1993 | 172 | |
| 13 | 1995 | 147 | |
| 14 | 1991 | 144 | |
| 15 | 1997 | 139 | |
| 16 | 1991 | 139 | |
| 17 | 2000 | 138 | |
| 18 | 1990 | 136 | |
| 19 | 1988 | 126 | |
| 20 | 1991 | 121 |
About Ralph Schwall
Ralph Schwall is a scholar working on Molecular Biology, Hepatology, Endocrinology, Diabetes and Metabolism, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 85 papers that have together received 10.2k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (28 papers), Liver physiology and pathology (24 papers), Growth Hormone and Insulin-like Growth Factors (12 papers), Organ Transplantation Techniques and Outcomes (9 papers), Reproductive Biology and Fertility (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Proteoglycans and glycosaminoglycans research (6 papers). The work is most often cited by research in Hepatology (1.3k citations), Oncology (2.4k citations), Molecular Biology (5.7k citations), Cancer Research (1.0k citations) and Reproductive Medicine (548 citations). Ralph Schwall has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Anthony J. Mason, Hartmut Koeppen, Sharon Fong, David A. Lawrence, Avi Ashkenazi, Andrea Hebert, Ling Chang, Zahra Shahrokh, Jeanine L. Bussiere and Laura DeForge. Their work appears in journals such as Endocrinology, Cancer Research, Journal of Biological Chemistry, Hepatology and Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.